February 1, 2019
Links to an abstract are available. For full text availability check your organization’s library.
A. “How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013,” by Frank R. Lichtenberg (w25483, January 2019, .pdf format, 23p.).
www.nber.org/papers/w25483
B. “The Impact of a Wartime Health Shock on the Postwar Socioeconomic Status and Mortality of Union Army Veterans and their Children,” by Dora Costa, Noelle Yetter, and Heather DeSomer (w25480, January 2019, .pdf format, 47p.).
www.nber.org/papers/w25480
C. “Is There a Demand for Reverse Mortgages in China? Evidence from Two Online Surveys,” by Katja Hanewald, Hazel Bateman, Hanming Fang, and Shang Wu (w25491, January 2019, .pdf format, 35p.).
www.nber.org/papers/w25491
Comments Off on CAAR – National Bureau of Economic Research Working Papers – February 1, 2019
“The Out-of-Pocket Cost Burden for Specialty Drugs in Medicare Part D in 2019,” by Juliette Cubanski, Wyatt Koma, and Tricia Neuman (January 2019, .pdf and HTML format, 16p.).
www.kff.org/medicare/issue-brief/the-out-of-pocket-cost-burden-for-specialty-drugs-in-medicare-part-d-in-2019/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – February 1, 2019
January 2, 2019
“Proposed Changes to Medicare Part D Would Benefit Drug Manufacturers More Than Beneficiaries,” by Shawn Bishop (January 2019).
www.commonwealthfund.org/blog/2019/proposed-changes-medicare-part-d-would-benefit-drug-manufacturers-more-beneficiaries
Comments Off on CAAR – Commonwealth Fund Blog – January 2, 2019
November 13, 2018
“Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial,” by Philippe Martin, Robyn Tamblyn, Andrea Benedetti, Sara Ahmed, and Cara Tannenbaum (Vol. 320, No. 18, November 13, 2018, p. 1889-1898).
jamanetwork.com/journals/jama/article-abstract/2714531
Comments Off on CAAR – Journal of the American Medical Association Article Abstract – November 13, 2018
September 27, 2018
“Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2017 Year-End Update,” by Leigh Purvis and Dr. Stephen Schondelmeyer (September 2018, .pdf format, 24p.).
www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html
Comments Off on CAAR – AARP Public Policy Institute Report – September 27, 2018
August 22, 2018
“Reducing Potential Overuse of Dementia Drugs Could Lead to Considerable Savings,” by Elizabeth A. Carter and Leigh Purvis (August 2018, .pdf format, 6p.).
www.aarp.org/ppi/info-2018/reducing-potential-overuse-of-dementia-drugs-could-lead-to-consi.html
Comments Off on CAAR – AARP Public Policy Institute Report – August 22, 2018
August 21, 2018
A. “Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents,” by Chana A. Sacks, ChangWon C. Lee, Aaron S. Kesselheim, and Jerry Avorn (Vol. 320, No. 7, August 21, 2018, p. 650-656).
jamanetwork.com/journals/jama/article-abstract/2697695
B. “Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia,” by Cécilia Samieri, Marie-Cécile Perier, Bamba Gaye, Cécile Proust-Lima, Catherine Helmer, Jean-François Dartigues, Claudine Berr, Christophe Tzourio, and Jean-Philippe Empana (Vol. 320, No. 7, August 21, 2018, p. 657-664).
jamanetwork.com/journals/jama/article-abstract/2697696
Comments Off on CAAR – Journal of the American Medical Association Article Abstracts – August 21, 2018
August 9, 2018
“Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2016 Average Sales Prices,” (OEI-03-18-00120, August 2018, .pdf format, 12p.).
oig.hhs.gov/oei/reports/oei-03-18-00120.asp
Comments Off on CAAR – US Department of Health and Human Services, Office of the Inspector General Report – August 9, 2018
June 26, 2018
“Prescription Drug Affordability and Innovation: Addressing Challenges in Today’s Market,” a hearing held June 26, 2018 (witness statement available in .pdf format, video of the full hearing available at the site, running time 2 hours 13 minutes). Note: The hearing begins at the 20:25 mark.
www.finance.senate.gov/hearings/prescription-drug-affordability-and-innovation-addressing-challenges-in-todays-market
Comments Off on CAAR – US Senate Committee on Finance Hearing Testimony – June 26, 2018
June 8, 2018
“The Food and Drug Administration Computed Prescription Drug User Fee Rates Accurately,” (A-05-17-00040, June 2018, .pdf format, 4p.).
oig.hhs.gov/oas/reports/region5/51700040.asp
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – June 8, 2018
June 4, 2018
“Increases in Reimbursement for Brand-Name Drugs in Part D,” (OEI 03 15 00080, June 2018, .pdf format, 15p.).
oig.hhs.gov/oei/reports/oei-03-15-00080.asp
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Brief – June 4, 2018
April 26, 2018
Links to an abstract are available. For full text availability check your organization’s library. “The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries,” by Frank R. Lichtenberg (w24536, April 2018, .pdf format, 46p.).
www.nber.org/papers/w24536
Comments Off on CAAR – National Bureau of Economic Research Working Paper – April 26, 2018
April 25, 2018
“Medication burden attributable to chronic co-morbid conditions in the very old and vulnerable,” by Kelly L. Moore, Kanan Patel, W. John Boscardin, Michael A. Steinman, Christine Ritchie, and Janice B. Schwartz (PLoS ONE 13(4): e0196109. doi.org/10.1371/journal.pone.0196109, XML, HTML, and .pdf format, 14p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0196109
Comments Off on CAAR – Public Library of Science (PLoS) Article – April 25, 2018
March 29, 2018
Comments Off on CAAR – US Senate Committee on Homeland Security and Government Affairs Minority Report – March 29, 2018
February 8, 2018
“How Do Prescription Drugs Affect the Use of Other Health Services?” by Gal Wettstein (IB No. 18-3, February 2018, .pdf format, 8p.).
How Do Prescription Drugs Affect the Use of Other Health Services?
Comments Off on CAAR – Center for Retirement Research at Boston College Issue Brief – February 8, 2018
January 29, 2018
Links to an abstract are available. For full text availability check your organization’s library.
A. “Targeting with In-kind Transfers: Evidence from Medicaid Home Care,” by Ethan M.J. Lieber and Lee M. Lockwood (w24267, January 2018, .pdf format, 74p.).
www.nber.org/papers/w24267
B. “Household Time Use Among Older Couples: Evidence and Implications for Labor Supply Parameters,” by Richard Rogerson and Johanna Wallenius (w24263, January 2018, .pdf format, 55p.).
www.nber.org/papers/w24263
C. “High-Priced Drugs in Medicare Part D: Diagnosis and Potential Prescription,” by Richard G. Frank and Richard J. Zeckhauser (w24240, January 2018, .pdf format, 41p.).
www.nber.org/papers/w24240
Comments Off on CAAR – National Bureau of Economic Research Working Papers – January 29, 2018
December 15, 2017
“Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015,” by Stephen W. Schondelmeyer and Leigh Purvis (December 2017, .pdf format, 16p.).
www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html
Comments Off on CAAR – AARP Public Policy Institute Report – December 15, 2017
November 7, 2017
“No Limit: Medicare Part D Enrollees Exposed to High Out-of-Pocket Drug Costs Without a Hard Cap on Spending,” by Juliette Cubanski, Tricia Neuman, Kendal Orgera, and Anthony Damico (November 2017, .pdf and HTML format, 13p.).
www.kff.org/medicare/issue-brief/no-limit-medicare-part-d-enrollees-exposed-to-high-out-of-pocket-drug-costs-without-a-hard-cap-on-spending/
Comments Off on CAAR – Kaiser Family Foundation Issue Brief – November 7, 2017
October 26, 2017
A. “Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia,” by Susan F. Wood, Joanna Podrasky, Meghan A. McMonagle, Janani Raveendran, Tyler Bysshe, Alycia Hogenmiller, and Adriane Fugh-Berman (PLoS ONE12(10): e0186060. doi.org/10.1371/journal.pone.0186060, HTML, XML, and .pdf format, 13p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0186060
B. “Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community-dwelling elderly population in Germany,” by Anne Fink, Nikolaus Buchmann, Christina Tegeler, Elisabeth Steinhagen-Thiessen, Ilja Demuth, and Gabriele Doblhammer (PLoS ONE12(10): e0187119. doi.org/10.1371/journal.pone.0187119, XML, HTML, and .pdf format, 15p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0187119
Comments Off on CAAR – Public Library of Science (PLoS) Articles – October 26, 2017
October 20, 2017
A. “Medicare Part D: A First Look at Prescription Drug Plans in 2018,” by Juliette Cubanski, Anthony Damico, Jack Hoadley, Kendal Orgera, and Tricia Neuman (October 2017, .pdf and HTML format, 21p.).
www.kff.org/medicare/issue-brief/medicare-part-d-a-first-look-at-prescription-drug-plans-in-2018/
B. “Medicare Advantage 2018 Data Spotlight: First Look,” by Gretchen Jacobson, Anthony Damico, and Tricia Neuman (October 2017, .pdf and HTML format, 5p.).
www.kff.org/medicare/issue-brief/medicare-advantage-2018-data-spotlight-first-look/
Comments Off on CAAR – Kaiser Family Foundation Issue Briefs – October 20, 2017
October 2, 2017
A. “Shortcomings of Device Claims Data Complicate and Potentially Increase Medicare Costs for Recalled and Prematurely Failed Devices,” (A-01-15-00504, September 2017, .pdf format, 28p.).
oig.hhs.gov/oas/reports/region1/11500504.asp
B. “Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2015 Average Sales Prices,” (OEI-03-17-00360, September 2017, .pdf format, 10p.).
oig.hhs.gov/oei/reports/oei-03-17-00360.asp
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Reports – October 2, 2017
September 12, 2017
A. “From Research to Standard Practice: Advancing Proven Programs to Support Family Caregivers of Persons Living with Dementia,” by Lynn Friss Feinberg (September 2017, .pdf format, 19p.).
www.aarp.org/ppi/info-2017/from-research-to-standard-practice.html
B. “Rx Price Watch Report: Trends in Retail Prices of Specialty Prescription Drugs Widely Used by Older Americans: 2006 to 2015,” by Leigh Purvis and Dr. Stephen Schondelmeyer (September 2017, .pdf format, 30p.).
www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html
Comments Off on CAAR – AARP Public Policy Institute Reports – September 12, 2017
August 3, 2017
“Prescription Drug Abuse among Older Adults,” by Olivia Dean (August 2017, .pdf format, 8p.).
www.aarp.org/ppi/info-2017/prescription-drug-abuse-among-older-adults.html
Comments Off on CAAR – AARP Public Policy Institute Report – August 3, 2017
July 31, 2017
The US Agency for Healthcare Research and Quality has released a new MEPS data file (July 2017, data in .zip or self decompressing [.exe] ASCII text and SAS Transport format, with documentation in HTML and .pdf format, and SAS and SPSS programming statements in ASCII format).
– MEPS HC-178A: 2015 Prescribed Medicines File
meps.ahrq.gov/mepsweb/data_stats/download_data_files_detail.jsp?cboPufNumber=HC-178A
Comments Off on CAAR – Medical Expenditure Panel Survey Data Release – July 31, 2017
January 19, 2017
“Improving Prescription Drug Safety for Canadian Seniors,” by Nicole F. Bernier (No. 61, January 2017, .pdf format, 19p.).
irpp.org/research-studies/study-no61/
Comments Off on CAAR – Institute for Research on Public Policy [Montreal, Quebec – Canada] Report – January 19, 2017
December 15, 2016
“Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2006 to 2015,” by Leigh Purvis and Dr. Stephen Schondelmeyer (December 2016, .pdf format, 30p.).
www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html
Comments Off on CAAR – AARP Public Policy Institute Report – December 15, 2016
September 12, 2016
“Generic Drugs Under Medicare: Part D Generic Drug Prices Declined Overall, but Some Had Extraordinary Price Increases,” (GAO-16-706, August 2016, .pdf format, 52p.).
www.gao.gov/products/GAO-16-706
Comments Off on CAAR – US Government Accountability Office Report – September 12, 2016
September 7, 2016
“CMS Should Address Medicare’s Flawed Payment System for DME Infusion Drugs,” (OEI-12-16-00340, September 2016, .pdf format, 11p.).
oig.hhs.gov/oei/reports/oei-12-16-00340.asp
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – September 7, 2016
July 12, 2016
“Use of medicines by older people with type 2 diabetes,” (July 2016, .pdf format, 120p.).
www.aihw.gov.au/publication-detail/?id=60129555607
Comments Off on CAAR – Australian Institute of Health and Welfare Report – July 12, 2016
May 16, 2016
A. “Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs,” by Roy H. Perlis and Clifford S. Perlis (PLoS ONE 11(5): e0155474. doi:10.1371/journal.pone.0155474, XML, HTML, and .pdf format, 12p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0155474
B. “The Incidence and Recurrence of Getting Lost in Community-Dwelling People with Alzheimer’s Disease: A Two and a Half-Year,” by Ming-Chyi Pai and Chih-Chien Lee (PLoS ONE 11(5): e0155480. doi:10.1371/journal.pone.0155480, XML, HTML, and .pdf format, 15p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0155480
Comments Off on CAAR – Public Library of Science (PLoS) Articles – May 16, 2016
April 28, 2016
“‘Valeant Pharmaceuticals’ Business Model: the Repercussions for Patients and the Health Care System,” a hearing held April 27, 2016 (witness statement available in .pdf format, video of the full hearing available at the site, running time 3 hours 1 minute). Note: Hearing begins at the 9:54 mark and ends at the 3:10:19 mark
www.aging.senate.gov/hearings/valeant-pharmaceuticals-business-model-the-repercussions-for-patients-and-the-health-care-system
Comments Off on CAAR – US Senate Special Committee on Aging Hearing Testimony – April 28, 2016
March 17, 2016
“Sudden Price Spikes in Decades-Old Rx Drugs: Inside the Monopoly Business Model,” a hearing held March 17, 2016 (witness statements available in .pdf format, video of the full hearing available at the site, running time 3 hours 14 minutes). Note: Hearing begins at the 18:03 mark and ends at the 3:32:05 mark.
www.aging.senate.gov/hearings/senate-special-committee-on-aging-to-hold-the-second-hearing-in-a-series-on-sudden-price-spikes-in-decades-old-rx-drugs
Comments Off on CAAR – US Senate Special Committee on Aging Hearing Testimony – March 17, 2016
December 17, 2015
“Average Manufacturer Prices Increased Faster Than Inflation for Many Generic Drugs,” (A-06-15-00030, December 2015, .pdf format, 7p.).
oig.hhs.gov/oas/reports/region6/61500030.asp
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – December 17, 2015
December 9, 2015
“Sudden Price Spikes in Off-Patent Drugs: Perspectives from the Front Lines,” a hearing held December 9, 2015 (witness statements in .pdf format, video of the full hearing available at the site, running time 1 hour 59 minutes). Note: Hearing begins at the 14:35 mark.
www.aging.senate.gov/hearings/sudden-price-spikes-in-off-patent-drugs_perspectives-from-the-front-lines
Comments Off on CAAR – US Senate Special Committee on Aging Hearing Testimony – December 9, 2015
November 20, 2015
“Rx Price Watch Report: Trends in Retail Prices of Specialty Drugs,” by Leigh Purvis and Dr. Stephen Schondelmeyer (November 2015, .pdf format, 29p.).
www.aarp.org/ppi/info-2015/trends-in-retail-prices-of-specialty-drugs.html
Comments Off on CAAR – AARP Public Policy Institute Report – November 20, 2015
November 16, 2015
Links to an abstract are available. For full text availability check your organization’s library.
A. “Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D,” by Abby Alpert, Darius Lakdawalla, and Neeraj Sood (w21714, November 2015, .pdf format, 66p.).
www.nber.org/papers/w21714
B. “Work Incentives in the Social Security Disability Benefit Formula,” by Gopi Shah Goda, John B. Shoven, and Sita Slavov (w21708, November 2015, .pdf format, 41p.).
www.nber.org/papers/w21708.pdf
Comments Off on CAAR – National Bureau of Economic Research Working Paper – November 16, 2015
November 5, 2015
“The Economic Burden of Out-of-Pocket Medical Expenditures Before and After Implementation of the Medicare Prescription Drug Program,” by Ayse Akincigil and Karen Zurlo (Working Paper No. 2015-28, November 2015, .pdf format, 20p.). Note: Links to the abstract and the full text of the paper available at:
crr.bc.edu/working-papers/the-economic-burden-of-out-of-pocket-medical-expenditures-before-and-after-implementation-of-the-medicare-prescription-drug-program/
Comments Off on CAAR – Center for Retirement Research at Boston College Working Paper – November 5, 2015
November 3, 2015
Note: The link below is to the table of contents for the current issue of JAMA (Vol. 314, No. 17, November 3, 2015). Check with your organization’s information center for availability.
jama.jamanetwork.com/issue.aspx?journalid=67&issueid=934629&direction=P
“Trends in Prescription Drug Use Among Adults in the United States From 1999-2012,” by Elizabeth D. Kantor, Colin D. Rehm, Jennifer S. Haas, Andrew T. Chan, and Edward L. Giovannucci (p. 1818-1830).
Comments Off on CAAR – Journal of the American Medical Association Articles – November 3, 2015
October 13, 2015
“Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study,” by Mary E. Tinetti, Gail McAvay, Mark Trentalange, Andrew B. Cohen, and Heather G. Allore (Vol. 351, No. 8028, .pdf and HTML format, BMJ 2015;351:h4984).
www.bmj.com/content/351/bmj.h4984
Comments Off on CAAR – British Medical Journal Article – October 13, 2015
October 6, 2015
“Medicare Part D at Ten Years: The 2015 Marketplace and Key Trends, 2006-2015,” by Jack Hoadley, Juliette Cubanski, and Tricia Neuman (October 2015, .pdf format, 59p.).
kff.org/medicare/report/medicare-part-d-at-ten-years-the-2015-marketplace-and-key-trends-2006-2015/
Comments Off on CAAR – Kaiser Family Foundation Report – October 6, 2015
August 19, 2015
A. “Sodium Intake and Socioeconomic Status as Risk Factors for Development of Age-Related Cataracts: The Korea National Health and Nutrition Examination Survey,” by Jeong Hun Bae, Doo Sup Shin, Sung Chul Lee, and In Cheol Hwang (PLoS ONE 10(8): e0136218. doi:10.1371/journal.pone.0136218, XML, HTML, and .pdf format, 11p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0136218
B. “Medication Underuse in Aging Outpatients with Cardiovascular Disease: Prevalence, Determinants, and Outcomes in a Prospective Cohort Study,” by Andreas D. Meid, Renate Quinzler, Julia Freigofas, Kai-Uwe Saum, Ben Schöttker, Bernd Holleczek, Dirk Heider, Hans-Helmut König, Hermann Brenner, and Walter E. Haefeli (PLoS ONE 10(8): e0136339. doi:10.1371/journal.pone.0136339, XML, HTML, and .pdf format, 12p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0136339
Comments Off on CAAR – Public Library of Science (PLoS) Articles – August 19, 2015
July 20, 2015
“To Switch or Be Switched: Examining Changes in Drug Plan Enrollment among Medicare Part D Low-Income Subsidy Enrollees,” by Jack Hoadley, Laura Summer, Elizabeth Hargrave, Samuel Stromberg, Juliette Cubanski, and Tricia Neuman (July 2015, .pdf format, 25p.).
kff.org/medicare/report/to-switch-or-be-switched-examining-changes-in-drug-plan-enrollment-among-medicare-part-d-low-income-subsidy-enrollees/
Comments Off on CAAR – Kaiser Family Foundation Report – July 20, 2015
June 25, 2015
A. “Influence of Retirement on Adherence to Statins in the Insurance Medicine All-Sweden Total Population Data Base,” by Heli Halava, Hugo Westerlund, Maarit Jaana Korhonen, Jaana Pentti, Mika Kivimaki, Linnea Kjeldgard, Kristina Alexanderson, and Jussi Vahtera (PLoS ONE 10(6): e0130901. doi:10.1371/journal.pone.0130901, HTML, XML, and .pdf format, 14p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0130901
B. “Effect of APOE and CD33 on Cognitive Decline,” by Kathleen M. Hayden, Michael W. Lutz, Maragatha Kuchibhatla, Cassandra Germain, and Brenda L. Plassman (PLoS ONE 10(6): e0130419. doi:10.1371/journal.pone.0130419, XML, HTML, and .pdf format, 10p.).
journals.plos.org/plosone/article?id=10.1371/journal.pone.0130419
Comments Off on CAAR – Public Library of Science (PLoS) Articles – June 25, 2015
June 2, 2015
“Rx Price Watch Report: Trends in Retail Prices of Generic Prescription Drugs Widely Used by Older Americans: 2006 to 2013,” by Dr. Stephen W. Schondelmeyer and Leigh Purvis (May 2015, .pdf format, 29p.).
www.aarp.org/health/drugs-supplements/info-08-2010/rx_price_watch.html
Comments Off on CAAR – AARP Public Policy Institute Report – June 2, 2015
March 30, 2015
Comments Off on CAAR – Life and Living in Advanced Age: a Cohort Study in New Zealand – Te Puawaitanga O Nga Tapuwae Kia Ora Tonu (LiLACS NZ) [University of Auckland, New Zealand Report – March 30, 2015
March 3, 2015
Links to an abstract are available. For full text availability check your organization’s library.
A. “Long-Term Care Utility and Late in Life Saving,” by John Ameriks, Joseph S. Briggs, Andrew Caplin, Matthew D. Shapiro, and Christopher Tonetti (w20973, March 2015, .pdf format, 48p.).
www.nber.org/papers/w20973
B. “Testing for Changes in the SES-Mortality Gradient When the Distribution of Education Changes Too,” by Thomas Goldring, Fabian Lange, and Seth Richards-Shubik (w20993, March 2015, .pdf format, 27p.).
www.nber.org/papers/w20993
C. “Prescription Drug Use under Medicare Part D: A Linear Model of Nonlinear Budget Sets,” by Jason Abaluck, Jonathan Gruber, and Ashley Swanson (w20976, March 2015, .pdf format, 59p.).
www.nber.org/papers/w20976
D. “The Wealth of Wealthholders,” by John Ameriks, Andrew Caplin, Minjoon Lee, Matthew D. Shapiro, and Christopher Tonetti (w20972, March 2015, .pdf format, 76p.).
www.nber.org/papers/w20972
Comments Off on CAAR – National Bureau of Economic Research Working Paper – March 3, 2015
February 27, 2015
“Comparing Average Sales Prices and Average Manufacturer Prices for Medicare Part B Drugs: An Overview of 2013,” (OEI-03-14-00520, February 2015, .pdf format, 12p.).
oig.hhs.gov/oei/reports/oei-03-14-00520.asp
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – February 27, 2015
“Expenditures for the Top Five Therapeutic Classes of Outpatient Prescription Drugs, Medicare Beneficiaries, Age 65 and Older, U.S. Civilian Noninstitutionalized Population, 2012,” by Marc Roemer (Statistical Brief No. 469, February 2015, .pdf and HTML format, 6p.).
meps.ahrq.gov/mepsweb/data_stats/Pub_ProdResults_Details.jsp?pt=Statistical+Brief&opt=2&id=1174
Comments Off on CAAR – Medical Expenditure Panel Survey Statistical Brief – February 27, 2015
February 24, 2015
“Does Medicare Part D Save Lives?” by Abe Dunn and Adam Hale Shapiro (Working Paper 2015-04, February 2015, .pdf format, 65p.).
Abstract:
This paper studies the impact of Medicare Part D on mortality for the population over the age of 65. We identify the effects of the reform using variation in drug coverage across counties before the reform was implemented. Studying mortality rates immediately before and after the reform, we find that cardiovascular-related mortality drops significantly in those counties most affected by Part D, while mortality rates for noncardiovascular diseases remain statistically unchanged. Estimates suggest that between 19,000 and 27,000 more individuals were alive in mid-2007 because of the Part D implementation in 2006.
www.frbsf.org/economic-research/files/wp2015-04.pdf
Comments Off on CAAR – Federal Reserve Bank of San Francisco (California) Working Paper – February 24, 2015
February 9, 2015
“Are Income-Based Public Drug Benefit Programs Fit for an Aging Population?” by Steven G. Morgan, Jamie R. Daw and Michael R. Law (December 2014, .pdf format, 27p.).
irpp.org/research-studies/study-no50/
Comments Off on CAAR – Institute for Research on Public Policy [Montreal, Quebec] Report – February 9, 2015
Older Posts »
